and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-
stage therapies...)-mediated diseases and an oral Factor D inhibitor as well as several early-
stage therapies, including one for light chain... -
Voir cette offre d'emploi